Literature DB >> 27920032

Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy.

Abdulmaged M Traish1,2, Jay C Vance2, Abraham Morgentaler3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27920032      PMCID: PMC5210128          DOI: 10.15252/embr.201643642

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  8 in total

1.  Bad science in the headlines. Who takes responsibility when science is distorted in the mass media?

Authors:  Andrew Moore
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

2.  Importance of the lay press in the transmission of medical knowledge to the scientific community.

Authors:  D P Phillips; E J Kanter; B Bednarczyk; P L Tastad
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

3.  Risks and benefits of hormone therapy: has medical dogma now been overturned?

Authors:  S Shapiro; T J de Villiers; A Pines; D W Sturdee; R J Baber; N Panay; J C Stevenson; A O Mueck; H G Burger
Journal:  Climacteric       Date:  2014-04-23       Impact factor: 3.005

Review 4.  Testosterone therapy and cardiovascular risk: advances and controversies.

Authors:  Abraham Morgentaler; Martin M Miner; Monica Caliber; Andre T Guay; Mohit Khera; Abdulmaged M Traish
Journal:  Mayo Clin Proc       Date:  2015-02       Impact factor: 7.616

5.  Menopause Management--Getting Clinical Care Back on Track.

Authors:  JoAnn E Manson; Andrew M Kaunitz
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

6.  Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions.

Authors:  Abraham Morgentaler; Michael Zitzmann; Abdulmaged M Traish; Anthony W Fox; T Hugh Jones; Mario Maggi; Stefan Arver; Antonio Aversa; Juliana C N Chan; Adrian S Dobs; Geoffrey I Hackett; Wayne J Hellstrom; Peter Lim; Bruno Lunenfeld; George Mskhalaya; Claude C Schulman; Luiz O Torres
Journal:  Mayo Clin Proc       Date:  2016-06-21       Impact factor: 7.616

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

8.  Effects of Testosterone Treatment in Older Men.

Authors:  Peter J Snyder; Shalender Bhasin; Glenn R Cunningham; Alvin M Matsumoto; Alisa J Stephens-Shields; Jane A Cauley; Thomas M Gill; Elizabeth Barrett-Connor; Ronald S Swerdloff; Christina Wang; Kristine E Ensrud; Cora E Lewis; John T Farrar; David Cella; Raymond C Rosen; Marco Pahor; Jill P Crandall; Mark E Molitch; Denise Cifelli; Darlene Dougar; Laura Fluharty; Susan M Resnick; Thomas W Storer; Stephen Anton; Shehzad Basaria; Susan J Diem; Xiaoling Hou; Emile R Mohler; J Kellogg Parsons; Nanette K Wenger; Bret Zeldow; J Richard Landis; Susan S Ellenberg
Journal:  N Engl J Med       Date:  2016-02-18       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.